UZH Life Sciences Fund
-
Type of investor
Seed Investor -
Based in
Zurich -
Number of investments
6-10 -
Industry
biotech, medtechVisit website of
UZH Life Sciences Fund
Related News
06.05.2025 14:20
metaLead secures CHF 1 million to tackle metal poisoning
29.02.2024 10:40
FimmCyte obtains CHF 1 million from the UZH Life Sciences Fund
02.09.2022 15:35
UZH Life Science Fund invests in Navignostics
16.10.2019 17:44
EraCal closes oversubscribed seed round
11.06.2019 14:01
Occlufit joins the UZH Life Sciences Fund portfolio
05.06.2019 10:55
The UZH Life Sciences Fund investS CHF1M in an anti-obesity drug
15.06.2018 10:00
Anaveon off to a good start with UZH Life Sciences Fund
30.08.2017 09:55
UZH Life Sciences Fund invests in first spin-off
The new Swiss Venture Capital Report was published on 26 January. It analyses 304 financing rounds closed in 2020 and includes further article such as an interview with Michael Hengartner, President of the ETH Board, and a list of Swiss "soonicorns". 
